• Infertile couples

• Women requiring egg/embryo cryopreservation

• Couples requiring preimplantation genetic diagnosis (PGD)

• Cancer patients requiring fertility preservation

• International patients

NTUH's Center of Reproductive Medicine operates with the mission of patient-centered care, integrated resources, continuous innovation, and high-quality clinical outcomes. Its team of many attending physicians, counselors, technicians, and fellows drives innovation across 10 reproductive medicine domains. Six global/international firsts: (1) World-first: egg thawing 3-hour spindle recovery >90% (Human Reproduction 2001, cover); (2) World-first: frozen egg survival/pregnancy rates equivalent to embryo freezing (2005); (3) World-first: whole-genome amplification for embryo gene/HLA testing (2008); (4) World-first PGD preventing hereditary hearing loss (cover); (5) World-first blastocyst biopsy + vitrification for neurofibromatosis PGD; (6) World-first sperm tail-end cutting ICSI technique. IVF live birth rates exceed Stanford University across all age groups; international patients account for 10.1% (2010–2011); 40 visiting physicians from worldwide (2006–2011).

• World-first: egg thawing spindle recovery theory and clinical application

• World-first PGD preventing hereditary hearing loss (cover article)

• World-first blastocyst biopsy + vitrification for genetic disease diagnosis

• World-first sperm tail-end cutting ICSI technique

• World-first: frozen egg survival/pregnancy rates equivalent to embryo freezing

• Multinational long-acting FSH clinical trial participation

• IVF cycles (Mar 2010–Mar 2011): 818; international patients 83 (10.1%)

• PGD cases: performed for multiple genetic diseases

• 2006–2011 visiting physicians: 40 from worldwide

• Embryonic stem cell paper: Human Reproduction cover (2007)

• IVF live birth rate: exceeds Stanford University across all age groups (2007–2009)

• PGD success: multiple world-first cases achieved healthy live births

• Embryonic stem cell differentiation into follicular structures: world-first report

• Long-acting FSH multinational trial: equivalent pregnancy rates (38.9% vs. 38.1%)

• Standardized SOP: daily CO2 and temperature monitoring in incubators

• Dual-member verification at every step

• Monthly lab and clinical quality meetings (medium, incubator, milliQ water QC)

• Monthly departmental meetings tracking pregnancy rates and improving protocols

• Patients send photos of newborns expressing gratitude

• 40 visiting physicians from worldwide (2006–2011)

• 2009: EU experts visited and positively affirmed research records and outcomes

• NTUH Center: clinical service, training, and research at world-class level

• Human Reproduction cover articles: 2001 and 2007

• Audiology and Neurotology cover article (PGD for hearing loss)

• 2007: International book chapter on oocyte vitrification

• 2011: International textbook chapter on ovulation stimulation in low-resource settings

• Invited international lectures: Italy, China, Japan, Korea, Singapore

• Established Taiwan's highest standard IVF and PGD service; live birth rates exceed Stanford

• Six global firsts benefiting infertile couples and elevating Taiwan's international status

• Attracts worldwide visiting physicians and international patients

• Long-acting FSH trial reduces injection burden and cost for patients

• Embryonic stem cell research lays foundation for regenerative medicine